New Delhi, India | 12th January 2026 — SEREKO, India’s first psychodermatology-led skincare brand, has been granted a patent for its proprietary stress recovery complex NeuroCalm®, marking a milestone in the evolution of science-backed skincare in India.
Developed after two years of research and development, NeuroCalm® is a patented psychodermatology complex designed to address stress responses in the skin. The patent grant establishes SEREKO as the first Indian skincare brand to secure intellectual property in the psychodermatology space, a field that sits at the intersection of dermatology, psychiatry, and neuroscience.
The innovation was conceptualised and led by Malvika Jain, Founder & CEO of SEREKO, in collaboration with Dr. Kriti Soni, a leading cosmetic scientist. Unlike traditional formulations that focus solely on surface-level symptoms, NeuroCalm® works by supporting the skin’s response to stress, helping reduce visible stress markers while improving overall skin health and balance.
“With NeuroCalm®, we wanted to challenge the idea that skincare is only about ingredients and routines,” said Malvika Jain, Founder of SEREKO. “This patent is not just a win for us as a brand — it’s a win for Indian skincare innovation and for consumers who are looking for solutions that understand the deeper causes behind skin concerns.”
About SEREKO
SEREKO was officially launched in June 2023, with a mission to go beyond surface-level solutions and target stress, the root cause of skin issues. The NeuroCalm® patent, granted in December 2025, validates the brand’s foundational belief that stress is not just felt emotionally, but visibly expressed through the skin.
